We are live on ! Find out more
HP

HealthInvest Partners Portfolio holdings

AUM $372M
1-Year Est. Return 59.89%
This Fund
S&P 500
This Quarter Est. Return
+13.65%
1 Year Est. Return
+59.89%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$128M
AUM Growth
–
Cap. Flow
+$119M
Cap. Flow %
93.48%
Top 10 Hldgs %
52.35%
Holding
45
New
45
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$9.82M
2
LLY icon
Eli Lilly
LLY
+$9.23M
3
GILD icon
Gilead Sciences
GILD
+$7.7M
4
COR icon
Cencora
COR
+$7.6M
5
MRK icon
Merck
MRK
+$6.82M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IONS icon
26
Ionis Pharmaceuticals
IONS
$9.21B
$1.23M 0.96%
+24,243
New +$1.16M
FUSN
27
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$1.2M 0.94%
+125,000
New +$607K
CYTK icon
28
Cytokinetics
CYTK
$10.6B
$980K 0.77%
+11,733
New +$425K
BBIO icon
29
BridgeBio Pharma
BBIO
$16.4B
$968K 0.76%
+23,985
New +$720K
EXAS
30
DELISTED
Exact Sciences
EXAS
$899K 0.7%
+12,157
New +$797K
ITCI
31
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$877K 0.69%
+12,245
New +$704K
AMAM
32
DELISTED
Ambrx Biopharma Inc
AMAM
$824K 0.64%
+57,847
New +$657K
KRYS icon
33
Krystal Biotech
KRYS
$9.68B
$822K 0.64%
+6,624
New +$735K
FOLD
34
DELISTED
Amicus Therapeutics
FOLD
$691K 0.54%
+48,710
New +$553K
SWAV
35
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$673K 0.53%
+3,530
New +$667K
MRUS
36
DELISTED
Merus
MRUS
$669K 0.52%
+24,325
New +$568K
INSP icon
37
Inspire Medical Systems
INSP
$1.71B
$657K 0.51%
+3,229
New +$523K
ACLX
38
DELISTED
Arcellx
ACLX
$633K 0.5%
+11,400
New +$514K
AUTL
39
Autolus Therapeutics
AUTL
$620M
$620K 0.49%
+96,345
New +$367K
MDGL icon
40
Madrigal Pharmaceuticals
MDGL
$12.4B
$586K 0.46%
+2,531
New +$443K
IMCR icon
41
Immunocore
IMCR
$1.74B
$534K 0.42%
+7,823
New +$407K
CABA icon
42
Cabaletta Bio
CABA
$455M
$477K 0.37%
+21,000
New +$353K
MORF
43
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$432K 0.34%
+14,952
New +$356K
AKRO
44
DELISTED
Akero Therapeutics
AKRO
$360K 0.28%
+15,432
New +$304K
PRTA icon
45
Prothena Corp
PRTA
$473M
$303K 0.24%
+8,342
New +$321K
1
2

Similar funds

KP
Kiltearn Partners Edinburgh, United Kingdom $372M AUM 18.16% 1-Year Est. Return
TCM
Thomist Capital Management Houston, Texas $371M AUM 77.62% 1-Year Est. Return
SAAM
Solus Alternative Asset Management Summit, New Jersey $372M AUM 45.33% 1-Year Est. Return
PC
Promethos Capital Boston, Massachusetts $372M AUM 23.19% 1-Year Est. Return
GIP
Gavilan Investment Partners Burlingame, California $372M AUM 6.04% 1-Year Est. Return
PC
Prevatt Capital Nassau, Bahamas $371M AUM 9.39% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
OCMH
Oxbow Capital Management (HK) Hong Kong $371M AUM 383.45% 1-Year Est. Return

HealthInvest Partners's Q4 2023 Portfolio in Review

Q4 2023 is the first quarter with a 13F filing on record for HealthInvest Partners, which disclosed 45 positions worth $128M. Its ten largest holdings account for 52% of the portfolio.

Its largest position is UnitedHealth: 18,408 shares worth $9.69M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • HealthInvest Partners's largest Q4 2023 buy was UnitedHealth: 18,408 shares worth $9.69M.
  • HealthInvest Partners's ten largest holdings make up 52% of its $128M portfolio in Q4 2023.
  • HealthInvest Partners disclosed 45 positions in Q4 2023, its first 13F filing on record.

Based on HealthInvest Partners's 13F filing for Q4 2023, filed 30 Jan 2024.